Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-06-16 18:00:11
Reporting Period:
Accepted Time:
2020-06-16 18:00:11
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1123494 Harvard Bioscience Inc HBIO Laboratory Analytical Instruments (3826) 043306140
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1195340 I Alan Edrick C/o Harvard Bioscience
84 October Hill Road
Hollilston MA 01746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-12 20,000 $2.63 67,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. This transaction was executed in multiple trades at prices ranging from $2.60 to $2.65, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Includes (a) a restricted stock unit award with 11,775 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020; and (b) 55,725 shares of common stock held by the Reporting Person.